Authors:
Marchand, M
van Baren, N
Weynants, P
Brichard, V
Dreno, B
Tessier, MH
Rankin, E
Parmiani, G
Arienti, F
Humblet, Y
Bourlond, A
Vanwijck, R
Lienard, D
Beauduin, M
Dietrich, PY
Russo, V
Kerger, J
Masucci, G
Jager, E
De Greve, J
Atzpodien, J
Brasseur, F
Coulie, PG
Van der Bruggen, P
Boon, T
Citation: M. Marchand et al., Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1, INT J CANC, 80(2), 1999, pp. 219-230
Authors:
Gileadi, U
Gallimore, A
Van der Bruggen, P
Cerundolo, V
Citation: U. Gileadi et al., Effect of epitope flanking residues on the presentation of N-terminal cytotoxic T lymphocyte epitopes, EUR J IMMUN, 29(7), 1999, pp. 2213-2222